Clinical Efficacy and Safety of Subcutaneous Immunotherapy With gpASIT+™ in Patients With Grass Pollen-induced Allergic Rhinoconjunctivitis
Clinical trial NCT03724240 · UNKNOWN
Trial details
- NCT number
- NCT03724240
- Sponsor
- ASIT Biotech S.A.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-01-02
- Primary completion
- 2019-09-01
- Enrollment
- 624
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.